The sensitivity and specificity of fecal DNA multi-target testing, including KRAS mutation, BMP3, and NDRG4 methylation, for CRC and advanced adenoma was 80%, 91.2%, and the corresponding area under the curve was 0.856. This evidence concerns the gene NDRG4 and colorectal carcinoma.